Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 379Triple Negative Breast Neoplasms 61Ovarian Neoplasms 46Prostatic Neoplasms 35Colorectal Neoplasms 35Neoplasms 28Carcinoma, Non-Small-Cell Lung 27Endometrial Neoplasms 24Lung Neoplasms 22Neoplasm Metastasis 21Uterine Cervical Neoplasms 19Melanoma 18Stomach Neoplasms 17Pancreatic Neoplasms 16Squamous Cell Carcinoma of Head and Neck 15Carcinoma, Renal Cell 14Urinary Bladder Neoplasms 13Sarcoma 12Head and Neck Neoplasms 12Esophageal Neoplasms 11Colonic Neoplasms 10Advanced Breast Cancer 9Small Cell Lung Carcinoma 8Carcinoma, Transitional Cell 8Anatomic Stage I Breast Cancer AJCC v8 8Liver Neoplasms 7Kidney Neoplasms 7Cholangiocarcinoma 7Carcinoma, Hepatocellular 6Brain Neoplasms 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuralgia × Breast × 30 days × Clear all
NCT06848348 2026-05-29

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Dogwood Therapeutics Inc.

Phase 2 Recruiting
240 enrolled
BreastGastrointestinal

Cancer Pain, Breast Neoplasms, Neoplasms, Neuralgia, Pain, Peripheral Nervous System Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡